InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Gitzstv Free
02/03/23 12:23 PM
profile icon
Pennyes Free
12/28/22 3:31 PM
profile icon
Renee PremiumMember
09/12/22 7:10 PM
profile icon
Jimmy Joe Free
01/03/22 12:18 PM
profile icon
docj Free
12/15/21 7:17 AM
profile icon
docj Free
12/09/21 6:37 AM
profile icon
docj Free
12/01/21 11:47 AM
profile icon
docj Free
11/23/21 10:16 AM
profile icon
Gitzstv Free
11/22/21 2:21 PM
profile icon
Jimmy Joe Free
11/19/21 8:12 PM
profile icon
docj Free
11/19/21 2:44 PM
profile icon
theSauceman Free
11/19/21 1:50 PM
profile icon
docj Free
11/18/21 5:33 AM
profile icon
NYD Free
10/22/21 11:21 AM
profile icon
docj Free
10/13/21 7:11 PM
profile icon
Jimmy Joe Free
10/12/21 1:35 PM
profile icon
docj Free
10/12/21 6:22 AM
profile icon
TheKid5 PremiumMember
10/01/21 11:25 AM
profile icon
docj Free
10/01/21 10:14 AM
profile icon
Jimmy Joe Free
08/23/21 11:22 AM
profile icon
docj Free
08/23/21 7:10 AM
profile icon
Jimmy Joe Free
08/23/21 2:09 AM
profile icon
Jimmy Joe Free
08/23/21 1:23 AM
profile icon
docj Free
08/20/21 4:29 PM
profile icon
TheKid5 PremiumMember
07/30/21 11:53 AM
profile icon
docj Free
07/21/21 7:01 AM
profile icon
docj Free
07/15/21 8:53 AM
profile icon
docj Free
05/21/21 4:49 PM
profile icon
Jimmy Joe Free
05/21/21 1:43 PM
profile icon
docj Free
05/10/21 6:46 AM
profile icon
bwolfy2002 Free
05/01/21 2:18 PM
profile icon
docj Free
05/01/21 7:09 AM
profile icon
docj Free
04/26/21 6:52 AM
profile icon
Jimmy Joe Free
04/17/21 3:52 AM
profile icon
docj Free
04/16/21 5:58 PM
profile icon
theSauceman Free
04/15/21 11:14 AM
profile icon
theSauceman Free
04/15/21 10:54 AM
profile icon
theSauceman Free
04/15/21 10:24 AM

NuGenerex Immuno-Oncology Inc (fka NUGX) RSS Feed

Followers
10
Posters
30
Posts (Today)
0
Posts (Total)
121
Created
03/15/21
Type
Free
Moderators

NuGenerex Immuno-Oncology, Inc. is a platform biotechnology company focused on harnessing the power of the innate immune system to treat cancer and infectious disease with a pipeline of immunotherapy indications based on our proprietary, patented platform technology, Ii-Key.

The Company’s lead immunotherapy product candidate is

AE37, an Ii-Key-HER2 peptide vaccine for breast, prostate, and bladder cancer which incorporates our li-peptide linker to a designated antigen that activates the immune system targeting specific cancer cells. Ex-Vivo human studies are currently underway for our Ii-Key-SARS-CoV-2 vaccine and clinical trials are expected to begin in early 2021.



https://nugenerexio.com/
Most Liked Posts
(Last 30 Days)
Board Info
Posts Today
0
Posts (Total)
121
Posters
30
Moderators
Most Liked Posts
(Last 30 Days)
New Post